A phase III study to access the safety and efficacy of prolgolimab 250 mg fixed dose administered every 3 weeks versus prolgolimab 1 mg/kg every 2 weeks in patients with metastatic... von Demidov, Lev, Kharkevich, Galina, Petenko, Natalia, Moiseenko, Vladimir, Protsenko, Svetlana, Semiglazova, Tatiana, Zimina, Anastasia, Kovalenko, Nadezhda, Fadeeva, Natalia, Kirtbaya, Dmitry, Belogortsev, Igor, Tantsyrev, Denis, Odintsova, Svetlana, Nesterova, Alfia, Vorontsova, Karina, Makarycheva, Yulia, Linkova, Yulia, Zinkina-Orikhan, Arina, Siliutina, Anna, Sorokina, Irina, Liaptseva, Daria, Chistyakov, Vladimir, Lutsky, Anton

Volltext

RANDOM SIGNAL SHAPER von VAVRIV DMITRIJ M,SU, CHERNYSHEV IGOR YU,SU, ODINTSOV BORIS L,SU, TRETYAKOV OLEG A,SU, KICHIN VLADIMIR I,SU, BELOGORTSEV ANDREJ B,SU, KALUGIN BORIS A,SU

Volltext bestellen

METHOD OF OBTAINING GLUCOSE von ZAKHAROV VALENTIN I,SU, BEZBORODOV ALEKSEJ M,SU, LOSYAKOVA LIDIYA S,SU, DE MILLO L,SU, BOCHKAREVA NINA G,SU, TAVOBILOV IGOR M,SU, MARTINOVICH LYUDMILA I,SU, ZAGUSTINA NATALIYA A,SU, BELOGORTSEV YURIJ A,SU, GAPPAROV MINKAIL M,SU, VASILEVA NATALYA V,SU, RODIONOVA NATALYA A,SU

Volltext bestellen